deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03993236

Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke

Moderate-intensity Rosuvastatin Plus Ezetimibe Versus High-intensity Rosuvastatin for Target LDL-C Goal Achievement in Patients With Recent Ischemic Stroke: a Randomized Clinical Trial

Sponsor: Chung-Ang University Hosptial, Chung-Ang University College of Medicine

Updated 10 times since 2019 Last updated: Oct 1, 2024 Started: Sep 9, 2019 Primary completion: Sep 27, 2021 Completion: Sep 27, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03993236, this PHASE4 trial focuses on Stroke, Ischemic and remains completed. Sponsored by Chung-Ang University Hosptial, Chung-Ang University College of Medicine, it has been updated 10 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jul 2019 – ~Mar 2020 · 8 months · monthly snapshotNot Yet Recruiting~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotRecruiting~Oct 2021 – ~Jan 2022 · 3 months · monthly snapshotRecruiting~Jan 2022 – ~Mar 2022 · 59 days · monthly snapshotRecruiting~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshotUnknown~Nov 2024 – ~Sep 2025 · 10 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

10 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Nov 2024 — Sep 2025 [monthly]

    Completed PHASE4

    Status: UnknownCompleted

  3. Sep 2024 — Nov 2024 [monthly]

    Unknown PHASE4

  4. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown StatusUnknown

  5. Mar 2022 — Jul 2024 [monthly]

    Unknown Status PHASE4

    Status: RecruitingUnknown Status

Show 5 earlier versions
  1. Jan 2022 — Mar 2022 [monthly]

    Recruiting PHASE4

  2. Oct 2021 — Jan 2022 [monthly]

    Recruiting PHASE4

  3. Jan 2021 — Oct 2021 [monthly]

    Recruiting PHASE4

  4. Mar 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

    Status: Not Yet RecruitingRecruiting

  5. Jul 2019 — Mar 2020 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chung-Ang University Hosptial, Chung-Ang University College of Medicine
  • Ewha Womans University Seoul Hospital
  • Hallym University Medical Center
  • Inje University Ilsan Paik Hospital
  • Keun-Sik Hong
  • Korea University Ansan Hospital
  • Korea University Guro Hospital
  • Kyunghee University Medical Center
  • Myongji Hospital
  • Samsung Medical Center
  • Seoul National University Hospital
  • Seoul St. Mary's Hospital
  • Severance Hospital
Data source: Inje University

For direct contact, visit the study record on ClinicalTrials.gov .